KALY - Kali Extracts Announces Patented Cannabis Extracts Targeting $170 In Million Pharmaceutical Treatments
April 15 2019 - 9:10AM
InvestorsHub NewsWire
KALY – Kali Extracts Announces
Patented Cannabis Extracts Targeting $170 In Million Pharmaceutical
Treatments
Dallas, TX -- April 15, 2019 --
InvestorsHub NewsWire -- Kali-Extracts, Inc. (Kali, Inc.
dba/Kali-Extracts, Inc.) (USOTC:
KALY) (“KALY”) has recently announced
ongoing cannabis extract research and development targeting four
specific health issues: Chronic Obstructive Pulmonary Disease
(COPD); Type 2 Diabetes; Cancer Pain Management, and Epilepsy.
The market for Type 2 Diabetes is expected to be a $64 billion market by 2026. The market
for COPD treatment is anticipated to reach $14 billion by 2025. The overall pain management treatment market is
anticipated to reach $83 billion by 2024. The market for
epilepsy treatment is anticipated to reach $9 billion by 2022. The company has
scheduled an online prestation this Wednesday, April
17th, where management will provide details on its
patented cannabis extract treatments targeting a $170 million
pharmaceutical market opportunity currently under development.
Beyond the
four specific cannabis therapies currently in various stages of
research and development, KALY has a number of additional target
therapies in its research pipeline which will be highlighted in the
April 17tt presentation.
To learn more about the company
visit https://www.kali-extracts.com/
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"),
and as such, may involve risks and uncertainties. These forward
looking statements relate to, amongst other things, current
expectation of the business environment in which the company
operates, potential future performance, projections of future
performance and the perceived opportunities in the market. The
company's actual performance, results and achievements may differ
materially from the expressed or implied in such forward-looking
statements as a result of a wide range of
factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214) 210-0459
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Apr 2023 to Apr 2024